Uline Antacid
NDC Package 69790-089-33

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Uline Antacid is do not use more than directedchew or crush tablets completely before swallowingdo not swallow tablets wholeAdults and children: (12 years and older) Chew 2 tablets every 2 or 3 hours as symptoms occur or as directed by a physician. Marketed by Uline, this product is identified by NDC 69790-089 and is authorized under FDA application M001.

Identification & Billing

NDC Package Code
69790-089-33
Package Description
50 PACKET in 1 BOX / 2 TABLET, CHEWABLE in 1 PACKET
Product Code
69790-089
11-Digit Billing Format
69790008933
RxNorm Crosswalk
  • RxCUI: 313884 - calcium carbonate 420 MG (Ca 168 MG) Chewable Tablet
  • RxCUI: 313884 - calcium carbonate 420 MG Chewable Tablet
  • RxCUI: 313884 - calcium carbonate 420 MG (calcium 168 MG) Chewable Tablet

Clinical Specifications

Proprietary Name
Uline Antacid
Dosage Form
-
Usage Information
Do not use more than directedchew or crush tablets completely before swallowingdo not swallow tablets wholeAdults and children: (12 years and older) Chew 2 tablets every 2 or 3 hours as symptoms occur or as directed by a physician. Do notexceed 19 tablets in 24 hours. Children under 12 years: Do not give to children under 12 years of age.

Regulatory & Marketing

Labeler Name
Uline
FDA Application #
M001
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-07-2019
End Marketing Date
03-01-2021
Listing Expiration
03-01-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69790-089-33 identifies a specific commercial package of 50 packet in 1 box / 2 tablet, chewable in 1 packet of Uline Antacid, labeled by Uline. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Uline on October 07, 2019. The current certification is valid through March 01, 2021.

How is this Uline product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69790008933. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69790-089-33
11-Digit CMS (5-4-2)
69790-0089-33

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.